Nanoelectronic breath analyzer and asthma monitor

• US 20070048180A1
• Filed: 05/18/2006
• Published: 03/01/2007
• Est. Priority Date: 09/05/2002
• Status: Abandoned Application

• Current Assignee: Nanomix Incorporated (CJY Holdings Ltd.)
• Original Assignee: Nanomix Incorporated (CJY Holdings Ltd.)
• Inventors: Valcke, Christian, Star, Alexander, Thomas, David, Joshi, Vikram, Niemann, Joseph, Gabriel, Jean-Christophe
• Application Number:
  US11/437,275
• Publication Number:
  US 20070048180A1
• Time in Patent Office: Days
• US Class Current: 422/57
• CPC Class Codes: B82Y 15/00 Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
• CPC Class Codes: G01N 33/497 of gaseous biological material, e.g. breath

Abstract

Nanoelectronic sensors, including sensors for detecting analytes such as CO₂, NO, anesthesia gases, and the like in human breath. An integrated multivalent monitor system is described which permits two or more analytes to be measured in breath, for example to monitor pulmonary conditions such as asthma. The monitor system may be configured to be compact, light weight, inexpensive, and to include a microprocessor capable of both analyzing measurements to determine patient status, and storing measurement history. Wireless embodiments provide such enhancements as remote monitoring.

Claims

1. A breath analyzer, comprising:

at least a first nanoelectronic sensor, the sensor including

a substrate;

one or more nanostructures disposed over the substrate;

one or more conducting elements in electrical communication with the nanostructure; and

at least one recognition material operatively associated with the first nanostructure, the at least one recognition material configured to provide a sensitivity to a first analyte found in human breath;

a breath sampler configured to sample at least the exhaled breath of a patient, and in communication with the sensor;

a processing unit configured to receive a signal from the first sensor and to use the signal to measure the concentration of the first analyte, so as to provide information related to a medical state of the patient.

2. The breath analyzer of claim 1, further comprising a output device to provide information related to the a medical state of the patient to a user.

3. The breath analyzer of claim 1, further comprising:

at least a second nanoelectronic sensor, the sensor including

a substrate;

one or more nanostructures disposed over the substrate;

one or more conducting elements in electrical communication with the nanostructure; and

at least one recognition material operatively associated with the first nanostructure, the at least one recognition material configured to provide a sensitivity to a second analyte found in human breath; and

wherein the processing unit is configured to receive a signal from the second sensor to use the signal to measure the concentration of the second analyte, so as to provide information related to a medical state of the patient.

4. The breath analyzer of claim 3, wherein the processing unit is configured to compare the measurement of the first analyte with the measurement of the second analyte, so as to determine a relationship between the measurements indicative of a medical state of the patient.

5. The breath analyzer of claim 4, wherein the first analyte includes carbon dioxide (CO₂) and the second analyte includes nitric oxide (NO).

6. The breath analyzer of claim 5, wherein the processing unit is configured to determine a relationship of the measured concentrations of CO₂ and NO in the sampled breath so as to provide an assessment of human airway inflammation of the patient.

7. The breath analyzer of claim 6, wherein the assessment of human airway inflammation of the patient is indicative of an asthma status, and the output device to provide information related to the an asthma status to a user.

8. The breath analyzer of claim 7, wherein the breath analyzer is substantially portable by a patient, and is configured to provide information related to the an asthma status to the patient on a substantially real-time basis.

9. The breath analyzer of claim 1, wherein the one or more nanostructures disposed over the substrate comprises a network of carbon nanotubes.

10. The breath analyzer of claim 9, wherein at least a portion of the network is in contact with the one or more conducting elements.

11. The breath analyzer of claim 10, wherein the one or more conducting elements include a source and a drain electrode separated from one another by a source-drain gap.

12. The breath analyzer of claim 11, wherein the network of carbon nanotubes comprises nanotubes having a characteristic length, and wherein the characteristic length is substantially less than the source-drain gap, so that the nanotubes comprising the network substantially contact at most only one of the source and drain electrodes.

13. The breath analyzer of claim 11, wherein the network of carbon nanotubes comprises nanotubes having a characteristic length, and wherein the characteristic length is substantially greater than the source-drain gap, so that a substantial portion of the nanotubes comprising the network contact both the source and the drain electrodes.

14. The breath analyzer of claim 1, further comprising a gate electrode;

and wherein the sensor signal is indicative of a property of the nanostructure under the influence of a gate voltage.

15. The breath analyzer of claim 1, wherein the sensor signal is indicative of a capacitance property of the nanostructure.

16. The breath analyzer of claim 4, wherein the first analyte and second analyte are selected from the group consisting essentially of CO₂, NO, NO₂, and H₂O₂.

17. The breath analyzer of claim 5, wherein the breath sampler is configured to delivery a continuing breath sample to either or both of the first sensor and the second sensor during at least a substantial portion of a patient exhalation;

and wherein the processing unit is configured to determine a history of the concentration of either or both of the first analyte and the second analyte during the exhalation.

18. The breath analyzer of claim 1, wherein the breath sampler is configured to control pressure of the breath sample during the course of a patient exhalation.